Non-Invasive Prenatal Diagnostics (Biochemical Screening) with calculation of individual risk for chromosomal abnormalities and fetal developmental defects using specialized computer programs

This tender concerns the provision of non-invasive prenatal diagnostic services, specifically biochemical screening for pregnant women. The procuring entity is not explicitly stated but the services are related to healthcare. The tender covers biochemical screening for the first trimester (11-13 weeks), including PAPP-A and free β-hCG, with genetic risk calculation using ASTRAIA software. It also includes screening for the second trimester (16-21 weeks) for AFP, free β-hCG, and estriol, with risk calculation using BRAHMS FastScreen PreIplus software. A specific provision is made for second-trimester screening for women who underwent first-trimester screening. The services fall under CPV code 85140000-2, which covers various health services. This procurement is vital for early detection of potential chromosomal abnormalities and fetal developmental defects, allowing for timely medical intervention and counseling.

This is a services contract in the health and medical services, information and communication technology and general supplies sectors, with a focus on Hospitals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 641,000.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.